Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dreyling

Showing results (71-80 of 103) with videos related to

Pageof 11
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2014
Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upM Dreyling, C Geisler, O Hermine, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 4, 2017
ESMO consensus conference on malignant lymphoma: general perspectives and recommendations for prognostic tools in mature B-cell lymphomas and chronic lymphocytic leukaemiaM Ladetto, C Buske, M Hutchings, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2016
ESMO consensus conference on malignant lymphoma: general perspectives and recommendations for prognostic tools in mature B-cell lymphomas and chronic lymphocytic leukaemiaM Ladetto, C Buske, M Hutchings, et al.
Genes, Chromosomes & Cancer|June 22, 2000
Marginal zone B-cell lymphomas (MZBL) arising at different sites represent different biological entitiesM M Ott, A Rosenwald, T Katzenberger, et al.
The Cochrane Database of Systematic Reviews|October 19, 2007
Chemotherapy plus Rituximab versus chemotherapy alone for B-cell non-Hodgkin's lymphomaH Schulz, J Bohlius, N Skoetz, et al.
Annals of Hematology|January 13, 2009
Allelic genotyping reveals a hierarchy of genomic alterations in mantle cell lymphoma associated to cell proliferationG Hutter, M Scheubner, G Ott, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2006
Initial chemotherapy with mitoxantrone, chlorambucil, prednisone impairs the collection of stem cells in patients with indolent lymphomas--results of a randomized comparison by the German Low-Grade Lymphoma Study GroupC Nickenig, M Dreyling, E Hoster, et al.
Leukemia|July 19, 2014
The EBMT/EMCL consensus project on the role of autologous and allogeneic stem cell transplantation in mantle cell lymphomaS Robinson, P Dreger, D Caballero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2025
Peripheral T- and natural killer-cell lymphomas: ESMO-EHA Clinical Practice Guideline for diagnosis, treatment and follow-upF d'Amore, M Federico, L de Leval, et al.
Leukemia|March 14, 2015
Safety and efficacy of Temsirolimus in combination with Bendamustine and Rituximab in relapsed mantle cell and follicular lymphomaG Hess, U Keller, C W Scholz, et al.
Pageof 11

Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2014
Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upM Dreyling, C Geisler, O Hermine, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 4, 2017
ESMO consensus conference on malignant lymphoma: general perspectives and recommendations for prognostic tools in mature B-cell lymphomas and chronic lymphocytic leukaemiaM Ladetto, C Buske, M Hutchings, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2016
ESMO consensus conference on malignant lymphoma: general perspectives and recommendations for prognostic tools in mature B-cell lymphomas and chronic lymphocytic leukaemiaM Ladetto, C Buske, M Hutchings, et al.
Genes, Chromosomes & Cancer|June 22, 2000
Marginal zone B-cell lymphomas (MZBL) arising at different sites represent different biological entitiesM M Ott, A Rosenwald, T Katzenberger, et al.
The Cochrane Database of Systematic Reviews|October 19, 2007
Chemotherapy plus Rituximab versus chemotherapy alone for B-cell non-Hodgkin's lymphomaH Schulz, J Bohlius, N Skoetz, et al.
Annals of Hematology|January 13, 2009
Allelic genotyping reveals a hierarchy of genomic alterations in mantle cell lymphoma associated to cell proliferationG Hutter, M Scheubner, G Ott, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2006
Initial chemotherapy with mitoxantrone, chlorambucil, prednisone impairs the collection of stem cells in patients with indolent lymphomas--results of a randomized comparison by the German Low-Grade Lymphoma Study GroupC Nickenig, M Dreyling, E Hoster, et al.
Leukemia|July 19, 2014
The EBMT/EMCL consensus project on the role of autologous and allogeneic stem cell transplantation in mantle cell lymphomaS Robinson, P Dreger, D Caballero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2025
Peripheral T- and natural killer-cell lymphomas: ESMO-EHA Clinical Practice Guideline for diagnosis, treatment and follow-upF d'Amore, M Federico, L de Leval, et al.
Leukemia|March 14, 2015
Safety and efficacy of Temsirolimus in combination with Bendamustine and Rituximab in relapsed mantle cell and follicular lymphomaG Hess, U Keller, C W Scholz, et al.
Pageof 11